- Clinical Research
- Sell Sheet
Evaluation of an IV Insulin Electronic Glucose Management System Using FDA Cleared Feature of EREI (Estimated Residual Extracellular Insulin) to Prevent Severe Hypoglycemia
A review was performed in early 2017 to provide needed information about the performance of the EndoTool® IV eGMS product cleared by the FDA in 2014 with EREI (estimated residual extracellular insulin), a feature to mitigate future insulin activity and hypoglycemia. See the retrospective review of the data.
Can Severe Hypoglycemia be Eliminated? Introducing Estimated Residual Extracellular Insulin (EREI)
Estimated Residual Extracellular Insulin (EREI) was introduced as an insulin infusion adjustment to account for future intravenous (IV) insulin activity within EndoTool. See the retrospective analysis demonstrating how EREI integrated into the eGMS significantly improves IV insulin dosing.
It’s About Time! Reducing Hypoglycemia in the Inpatient Setting
This on demand webinar discusses the common causes for inpatient hypoglycemia, including the timing of blood glucose checks and insulin delivery, and initiatives that can be taken to reduce hypoglycemia.
Measuring the Return on Investment for Inpatient Glycemic Management
Data can and should drive decisions about how glycemic management is provided in your organization. Learn how a return on investment can help set priorities and fund initiatives.
Using Whiteboard Animation Videos for Diabetes Education: Meet “Lynn”
Whiteboard animation videos can provide engaging and memorable diabetes education for patients and providers. Download this poster to learn the benefits and how to create your own whiteboard animation videos.
Mind the Gap: Utilizing a Gap Analysis to Facilitate Inpatient Glycemic Management Performance Improvement
There is a significant opportunity to improve glycemic management by conducting a gap analysis. Download this poster to see the steps and benefits.
Diabetes Management Matters
This whiteboard animation video, Diabetes Management Matters, explains the importance of inpatient glycemic management.
Patrick Burgess, MD: Hypoglycemia and Impact of Late Glucose Checks
Patrick Burgess, MD, PhD, founder and inventor of EndoTool, sat down with MD Magazine® to discuss his study on the impact of late glucose checks as well as other important topics being covered at the American Diabetes Association’s 79th Scientific Sessions.